U.S. markets close in 13 minutes

Bayer Aktiengesellschaft (BAYN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
67.990.00 (0.00%)
At close: 4:53PM CEST
Sign in to post a message.
  • C
    Capatina
    I have invested in this company without doing any research since it seamed it would put themselves together after the roundup settlement but now I am not sure. I would really like some others to share their thoughts about this company.
    Neutral
  • a
    addis
    Morgan Stanley reiterates but rating with Euro 68 as price target !!!!
  • S
    Sebastiaan
    Almost behaving like a oil major..

    As the cashflows seem unaffected and they have a decent approach on RNA treatment, it seems quite futureproof.

    I might look to initiate a first position.
  • a
    addis
    Decade low price and double bottom being tested. If they announce more settlements (which are imminent), should result in 10% rise by November 10th. Pretty much most weak hands have been taken out. It is darkest before dawn ........! Today’s news about French loss is a yawner except for headline risk.....exposure is of $1mm and there is minimal risk of class action like in the U.S. When there appears to be no catalyst for rise, always something sticks ......this stock is trading at half the valuation of steel stocks (pessimism is extreme), and litigation charges are already baked in !
  • a
    addis
    I have loaded up big time at this price! The enterprise value to ebitda stands at 5.7x only, and equity value as upside of 50% plus within 12 months with cushion of nearly 6% dividend yield while waiting. Bad news priced in already, and as cost reductions flow thru, cashflow will continue to climb. Despite the disastrous Monsanto acquisition, all current assets deserve a valuation multiple of 8x.....thereby implying equity valuation would double from here within 2 years.
  • C
    Capatina
    I see a huge fall today everywhere and Bayer is no exception. I think it will go eventually as low as 30 p/share. They should change asp they’re ceo
  • H
    HvR
    Is Bayer the big short? I bought heavily at #$%$54. It seems lost this year. I will wait until March ex dividend.
  • A
    Alex
    They are still world market leader in crop sciences. The corona effect causes lower prices but in the long term prices should raise again due to growing world population. Plus they have a strong pharma business.Bayer is valued as it would go bankrupt soon, but they still make billions of profit every year, although next year's profit has been cut by 15 %. I added at 44,50 #$%$and will buy more if it drops lower.
  • a
    addis
    Good news is that according to “legal experts”, given company’s recent settlement of most contentious lawsuits with attorneys who had previously gone to trials, the odds of legal settlement with remaining lawsuits is very good. I can thus see this huge overhang disappearing soon, resulting in a much greater confidence for company’s future.
  • R
    Rocky
    I don’t recall this stock ever going up. Lol
  • M
    Mitra
    Finally, I added shares here. I am looking into it for atleast 5 years. I wish dividends are quarterly .
  • s
    stocktargetadvisor
    $BAYRY
    Target Set by Barclays Buy EUR 75
    Target Set by Sanford Bernstein Buy EUR 83.41
    Target Set by Barclays Capital Buy EUR 75
  • K
    KingOfBK
    "The time has come for Monsanto to end its baseless appeals and pay Mr. Johnson the money it owes him.” Today California Supreme Court refused to review Monsanto's trial loss to Lee Johnson. Statement from Lee's lawyers:
    “The Miller Firm is pleased that the California Supreme Court denied Monsanto's latest attempt to skirt responsibility for the significant harm it caused Mr. Johnson. Multiple judges have now affirmed the jury’s unanimous finding that Monsanto maliciously concealed Roundup's cancer risk and caused Mr. Johnson to develop a deadly form of cancer. The time has come for Monsanto to end its baseless appeals and pay Mr. Johnson the money it owes him.”
  • D
    Didier
    Holding a very small position around #$%$55, anyone an educated guess around what price point to possibly double up? Intend to hold for multiple years
  • E
    Earl
    .. I don't understand why Bayer would spend so much Money to acquire Monsanto . Surely with that much Money , Bayer could have made a much better acquisition that would have enhanced share price . I suppose Bayer must have obviously saw something with monsanto , that other Investors do not.
  • j
    john
    Grabbing some of this soon,
  • g
    grubie024
    This stock is starting to upset me
  • C
    Capatina
    Dan you are probably right otherwise I can’t explain how they don’t even bother to come forward with a strong strategy, and they keep showing numbers that are not relevant for investors at least not in short term. I pulled out today with a huge loss since I see it’s only going to go down.
    Bearish
  • A
    Andy
    Main Roundup Ingredient Is Unsafe At Nearly ALL Levels
    www.youtube.com
  • P
    Peter
    I believe this company will thrive, incredible people and talent and tradition to excellence. Pipeline is re surging, company over 40B in sales a year, well diversified. Now with Baumann confirmed , stability is guaranteed. And pay attention to their Soccer team too!
    Bullish